Sign up free

Veraxa Biotech AG - Post de-SPAC (VRXA) insider trading

Veraxa Biotech AG - Post de-SPAC insiders have made 3 open-market purchases worth $53k since Sep 29, 2026, by 3 different insiders. The latest: Marc Gruninger (Director) bought $10k, filed Oct 29, 2026, scored 34 out of 100. The biggest: $33k by Christoph Samuel Ziegler, filed Oct 21, 2026.

Follow VRXA, freeOpen the live feed

A free account gets an alert the minute a new buy or sale is filed.

+$53knet insider buying, 90 days
+$53knet insider buying, 12 months
3 · 0insiders buying · selling, 12 months
34score of the latest buy, Oct 29

Insider purchases

FiledInsiderStakeScoreBought1 week1 month
Oct 29
Form 4 (opens sec.gov)
Marc GruningerDirectorDirector · Near 52-week low · Penny stock: hard to trade New position 34 $10k
10,000 at $1.00
——
Oct 21
Form 4 (opens sec.gov)
Christoph Samuel ZieglerDirectorDirector · Penny stock: hard to trade +378% stake 34 $33k
30,000 at $1.09
+9.7%waiting
Sep 29
Form 4 (opens sec.gov)
Warren HosseinionDirector · filed lateDirector · Filed late · Penny stock: hard to trade +1% stake 1 $10k
6,024 at $1.67
——

Track record (hypothetical): a week after the filing, these buys averaged +9.7% (100% up, 1 measured).

Insiders who bought VRXA

Questions

Are insiders buying VRXA stock?

Yes. In the last 90 days, 3 open-market purchases were filed, worth $53k.

Who bought VRXA stock most recently?

Marc Gruninger, Director, bought 10,000 shares for $10k (Form 4 (opens sec.gov), filed Oct 29, 2026).

How does InsiderBeacon score an insider buy?

Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.

Insiders are also buying, same industry

Data as of Oct 29, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer

Follow insiders. Sell when they sell.Free in early access, no card

Sign up free